Skip to main content
High RiskFDAfda-F-0372-2018OTHER

Chicken of the Sea Pasteurized Crabmeat Lump Blend, Item #411820; Chicken of the Sea Pasteurized Crabmeat Claw, Item #370810; Jack's Catc...

Units Affected
353
Recall Date
October 24, 2017
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0372-2018.

The firm is initiating a recall due to potential temperature abuse to product during transit.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0372-2018.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Performance Food Group, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0372-2018.

Performance Food Group, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Performance Food Group, Inc. Recall FAQ

Performance Food Group, Inc. is the subject of a meat & poultry safety report: Chicken of the Sea Pasteurized Crabmeat Lump Blend, Item #411820; Chicken of the Sea Pasteurized Crabmeat Claw, Item #370810; Jack's Catc.... The notice was published on October 24, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 353 units are potentially affected.